ImtiazAMalikMD

PubMed

• 34 citations
  Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: a randomized phase 2 study.
  Jeffrey R. Infante, Tony R. Reid, Allen Lee Cohn, William Jeffery Edenfield, Terrence P. Cescon, John T. Hamm, Imtiaz Malik, Thomas A. Rado, Philip J. McGee, Donald A....> ;Cancer. 2013 Jul 15
• 6 citations
  A Phase I Study Of Docetaxel, Oxaliplatin, & Capecitabine (DOC) As First-Line Therapy of Patients With Locally Advanced or Metastatic Adenocarcinoma of Stomach and GE ...
  Imtiaz A. Malik, Pedro Bernal, Janet Byrd> ;Cancer Investigation. 2010 Sep 14
• 48 citations
  A randomized, placebo-controlled phase ii study evaluating the reduction of neutropenia and febrile neutropenia in patients with colorectal cancer receiving pegfilgras...
  J. Randolph Hecht, Madhavan V. Pillai, Russell Gollard, William Heim, Forrest Swan, Ravi Patel, Lyndah Dreiling, May Mo, Imtiaz Malik> ;Clinical Colorectal Cancer. 2010 Apr 1
• 6 citations
  A phase I study of capecitabine, irinotecan, celecoxib, and radiation as neoadjuvant therapy of patients with locally advanced rectal cancer.
  Imtiaz A. Malik, Farabi Hussein, David A. Bush, Munther Alqaisi, Pedro Bernal, Janet Byrd, Carlos A. Garberoglio> ;American Journal of Clinical Oncology. 2009 Oct 1
• Pegfilgrastim in colorectal cancer (CRC) patients (pts) receiving every-two-week (Q2W) chemotherapy (CT): Long-term results from a phase II, randomized, controlled study.
  Hecht JR, Pillai M, Gollard R, Dreiling L, Mo M, Malik I> ;J. Clin. Oncol.. 2009-05-20
• 153 citations
  Panitumumab monotherapy in patients with previously treated metastatic colorectal cancer
  J. Randolph Hecht, Amita Patnaik, Jordan Berlin, Alan P. Venook, Imtiaz Malik, Simon Tchekmedyian, Lynn Navale, Rafael G. Amado, Neal J. Meropol> ;Cancer. 2007 Sep 1
• 71 citations
  Panitumumab with irinotecan/leucovorin/5-fluorouracil for first-line treatment of metastatic colorectal cancer.
  Jordan Berlin, James Posey, Simon Tchekmedyian, Eddie H. Hu, David Chan, Imtiaz Malik, Liqiang Yang, Rafael G. Amado, J. Randolph Hecht> ;Clinical Colorectal Cancer. 2007 Mar 1
• 29 citations
  Darbepoetin Alfa Administered Every Three Weeks Is Effective for the Treatment of Chemotherapy-Induced Anemia
  Ralph V Boccia, Imtiaz A. Malik, Vinay Raja, Stephen Kahanic, Randall Liu, Tom Lillie, Dianne Tomita, Billy Clowney, Peter T. Silberstein> ;The Oncologist. 2006 Apr 1
• Safety and efficacy of panitumumab monotherapy in patients with metastatic colorectal cancer (mCRC).
  Malik I, Hecht JR, Patnaik A, Venook A, Berlin J, Croghan G, Navale L, MacDonald M, Jerian S, Meropol NJ> ;J. Clin. Oncol.. 2005-06-01
• ABX-EGF monotherapy in patients (pts) with metastatic colorectal cancer (mCRC): An updated analysis.
  Hecht JR, Patnaik A, Malik I, Venook A, Berlin J, Croghan G, Wiens BL, Visonneau S, Jerian S, Meropol NJ> ;J. Clin. Oncol.. 2004-07-15
• 15 citations
  Gallbladder cancer: current status.
  Imtiaz A. Malik> ;Expert Opinion on Pharmacotherapy. 2004 Jun 1
• 9 citations
  Effect of subcutaneous injection of granulocyte-macrophage colony stimulating factor (GM-CSF) on healing of chronic refractory wounds.
  Imtiaz A. Malik, Maliha Zahid, Saba Haq, Serajuddaula Syed, Imran Moid, Irshad Waheed> ;The European Journal of Surgery = Acta Chirurgica. 2003 Nov 27
• An autopsy study of hypertrophic cardiomyopathy.
  Ahmad M, Afzal S, Malik IA, Mushtaq S, Mubarik A> ;J Pak Med Assoc. 2003-10-01
• 8 citations
  Clinicopathological features and management of gallbladder cancer in Pakistan: A prospective study of 233 cases
  Imtiaz A. Malik> ;Journal of Gastroenterology and Hepatology. 2003 Aug 1
• 63 citations
  Gemcitabine and Cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder.
  Imtiaz A. Malik, Zeba Aziz, Manzoor S. H. Zaidi, Gopalan Sethuraman> ;American Journal of Clinical Oncology. 2003 Apr 1
• Prospective evaluation of efficacy and toxicity of 5-fu and folinic acid (Mayo Clinic regimen) in patients with advanced cancer of the gallbladder.
  Malik, I.A., Aziz, Z.> ;Am J Clin Oncol. 2003 Apr
• 119 citations
  Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan
  Alexander Liede, Imtiaz A. Malik, Zeba Aziz, Patricia de los Rios, Elaine Kwan, Steven A. Narod> ;American Journal of Human Genetics. 2002 Sep 1
• 49 citations
  Use of CAM results in delay in seeking medical advice for breast cancer.
  Imtiaz A. Malik, Sethuraman Gopalan> ;European Journal of Epidemiology. 2002 Aug 1
• Comparison of meropenem with ceftazidime as monotherapy of cancer patients with chemotherapy induced febrile neutropenia.
  Malik I> ;J Pak Med Assoc. 2002-01-01
• Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis.
  Malik I, Danesh J, Whincup P, Bhatia V, Papacosta O, Walker M, Lennon L, Thomson A, Haskard D> ;Lancet. 2001-09-22
• 10 citations
  Altretamine is an effective palliative therapy of patients with recurrent epithelial ovarian cancer.
  Imtiaz A. Malik> ;Japanese Journal of Clinical Oncology. 2001 Feb 1
• 32 citations
  Use of unconventional methods of therapy by cancer patients in Pakistan.
  Imtiaz A. Malik, Naseeruddin A. Khan, Waseem Khan> ;European Journal of Epidemiology. 2000 Feb 1
• 4 citations
  Prospective randomized comparison of tropisetron with and without dexamethasone against high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced ...
  Imtiaz A. Malik, Imran Moid, Zubair Khan, Masood Hussain> ;American Journal of Clinical Oncology. 1999 Apr 1
• 65 citations
  A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia
  Imtiaz A. Malik, Imran Moid, Zeba Aziz, Shireen Khan, Mohammad Suleman> ;The American Journal of Medicine. 1998 Dec 1
• Role of fibreoptic bronchoscopy in the management of immunocompromised patients with pulmonary infiltrates.
  Hussain SF, Malik I, Khan JA> ;J Pak Med Assoc. 1998-10-01
• Join now to see all